Tesamorelin
Trans-3-hexenoyl GHRH(1-44) analogue
- Brands
- 4
- Best purity
- 99.47%
- From
- £60
- Price spread
- £44
4 brands supply this
Ordered by price · no paid placement
- RP-HPLC · NOR-202608-152Janoshik AnalyticalRetention time (min)λ 214 nm
- Released
- 2026-08-22
- Water (KF)
- 3.13%
- Endotoxin
- 0.118 EU/mg
- RP-HPLC · VER-202608-152Colmaric AnalyticalsRetention time (min)λ 214 nm
- Released
- 2026-08-22
- Water (KF)
- 3.13%
- Endotoxin
- 0.118 EU/mg
- RP-HPLC · HAL-202608-152Janoshik AnalyticalRetention time (min)λ 214 nm
- Released
- 2026-08-22
- Water (KF)
- 3.13%
- Endotoxin
- 0.118 EU/mg
- RP-HPLC · COR-202608-152Peak ChromatographyRetention time (min)λ 214 nm
- Released
- 2026-08-22
- Water (KF)
- 3.13%
- Endotoxin
- 0.118 EU/mg
The compound
A 44-residue GHRH analogue carrying an N-terminal trans-3-hexenoyl moiety. Long-chain synthesis; each lot carries extended purity documentation given the sequence length.
- CAS number
- 218949-48-5
- Molecular formula
- C221H366N72O67S
- Molecular weight
- 5135.87 g/mol
- Solubility
- Bacteriostatic water or 0.9% NaCl, ≥2 mg/mL
- Storage
- −20 °C, desiccated
- Reconstituted
- 2–8 °C, use within 28 days
Primary structure
44 residues
Hover a residue for detail
- Formula
- C221H366N72O67S
- Molecular weight
- 5135.87 g/mol
Interactive
Reconstitution calculator
Vial mass
mL
mcg
Syringe
- Draw to
- 25.0 units
- Volume
- 0.250 mL
- Concentration
- 1.00 mg/mL
- Draws per vial
- 8
Arithmetic for Tesamorelin at the values you entered. Not a protocol and not a dose recommendation. Research use only.